AU2003230891A8 - Anticancer anthraquinones and method of use thereof - Google Patents

Anticancer anthraquinones and method of use thereof

Info

Publication number
AU2003230891A8
AU2003230891A8 AU2003230891A AU2003230891A AU2003230891A8 AU 2003230891 A8 AU2003230891 A8 AU 2003230891A8 AU 2003230891 A AU2003230891 A AU 2003230891A AU 2003230891 A AU2003230891 A AU 2003230891A AU 2003230891 A8 AU2003230891 A8 AU 2003230891A8
Authority
AU
Australia
Prior art keywords
anthraquinones
anticancer
anticancer anthraquinones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003230891A
Other versions
AU2003230891A1 (en
Inventor
Yanjun Zhang
Navindra P Seeram
Muraleedharan G Nair Nair
Robert H Cichewicz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Michigan State University MSU
Original Assignee
Michigan State University MSU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/317,906 external-priority patent/US6800615B2/en
Application filed by Michigan State University MSU filed Critical Michigan State University MSU
Publication of AU2003230891A1 publication Critical patent/AU2003230891A1/en
Publication of AU2003230891A8 publication Critical patent/AU2003230891A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12—Acetic acid esters
    • C07C69/14—Acetic acid esters of monohydroxylic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/38—Quinones containing —CHO or non—quinoid keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/24—Anthracenes; Hydrogenated anthracenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003230891A 2002-04-15 2003-04-11 Anticancer anthraquinones and method of use thereof Abandoned AU2003230891A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US37257602P 2002-04-15 2002-04-15
US60/372,576 2002-04-15
US38936802P 2002-06-17 2002-06-17
US60/389,368 2002-06-17
US10/317,906 2002-12-12
US10/317,906 US6800615B2 (en) 2002-04-15 2002-12-12 Antihelminthic anthraquinones and method of use thereof
US10/355,483 US6875746B1 (en) 2002-04-15 2003-01-31 Anticancer anthraquinones and method of use thereof
US10/355,483 2003-01-31
PCT/US2003/011302 WO2003089576A2 (en) 2002-04-15 2003-04-11 Anticancer anthraquinones and method of use thereof

Publications (2)

Publication Number Publication Date
AU2003230891A1 AU2003230891A1 (en) 2003-11-03
AU2003230891A8 true AU2003230891A8 (en) 2003-11-03

Family

ID=29255565

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003230891A Abandoned AU2003230891A1 (en) 2002-04-15 2003-04-11 Anticancer anthraquinones and method of use thereof

Country Status (2)

Country Link
AU (1) AU2003230891A1 (en)
WO (1) WO2003089576A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008012904A (en) 2006-04-07 2009-03-06 Sunten Phytotech Co Ltd Anthracenedione compounds.
CN112441925B (en) * 2020-11-13 2022-04-01 宁波大学 Anthraquinone compound and preparation method thereof from ranunculus spinosus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ26693A3 (en) * 1992-02-28 1993-12-15 Lilly Industries Ltd Pharmaceutical compositions
US5652265A (en) * 1995-03-29 1997-07-29 Wisconsin Alumni Research Foundation Production of rhein and rhein derivatives

Also Published As

Publication number Publication date
WO2003089576A3 (en) 2003-12-31
AU2003230891A1 (en) 2003-11-03
WO2003089576A2 (en) 2003-10-30

Similar Documents

Publication Publication Date Title
AU2003288902A8 (en) Microcapsules and methods of use
EP1465615A4 (en) Tricyclic-bis-enone derivatives and methods of use thereof
PL375691A1 (en) Imidazolopyridines and methods of making and using the same
AU2003259735A8 (en) Small-mer compositions and methods of use
HK1079789A1 (en) Vasculostatic agents and methods of use thereof
AU2003217870A8 (en) Pini-modulating compounds and methods of use thereof
EP1521747A4 (en) Receptor-type kinase modulators and methods of use
EP1508604A4 (en) Heat-expanding microcapsule and use thereof
IL164703A0 (en) ImidazoÄ1,2-AÜpyrazin-8-ylamines method of making and method of use thereof
AU2003213673A8 (en) Pin1-modulating compounds and methods of use thereof
HK1070849A1 (en) Catheter and use method thereof
AU2003259717A8 (en) Modulators of rabggt and methods of use thereof
EP1551384A4 (en) R-nsaid esters and their use
IL164193A0 (en) Combined use of antitumor indolopyrrolocarbazole derivative and other antitumor agent
EP1476150A4 (en) Carboxyfullerenes and methods of use thereof
AU2003299441A8 (en) Nf-hev compositions and methods of use
AU2003296369A8 (en) Imminoamines and preparation thereof
AU2003224943A8 (en) Antihelminthic anthraquinones and method of use thereof
EP1605814A4 (en) Guided retractor and methods of use
AU2003215244A8 (en) Complexes and methods of using same
AU2002363938A8 (en) Methods and use of motoneuronotropic factors
EP1491091A4 (en) Insect-proofing means and method of insect-proofing
AU2003297612A8 (en) 2-substituted-3-propenamide derivatives and methods of using the same
EP1545287A4 (en) Vasoregulating compounds and methods of their use
AU2003287802A1 (en) Palpometer and methods of use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase